Artwork

Content provided by Hepatitis B Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hepatitis B Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

A Conversation with Dr. Stephan Urban, Who Developed the First Drug for hepatitis D

14:11
 
Share
 

Manage episode 337234682 series 3380302
Content provided by Hepatitis B Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hepatitis B Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This is a special edition episode - Ed Tate, Director of Communications at the Hepatitis B Foundation was able to sit down with Dr. Stephan Urban the developer of the hepatitis D drug, Hepcludex. The drug, which blocks the entry of the hepatitis B and hepatitis D virus into the liver cell, was approved by the European Commission on 31 July 2020. Listen for more of their conversation.
Consider donating here to support programs like B Heppy!
Questions? Send them to: info@hepb.org

Support the Show.

Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook

  continue reading

52 episodes

Artwork
iconShare
 
Manage episode 337234682 series 3380302
Content provided by Hepatitis B Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hepatitis B Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This is a special edition episode - Ed Tate, Director of Communications at the Hepatitis B Foundation was able to sit down with Dr. Stephan Urban the developer of the hepatitis D drug, Hepcludex. The drug, which blocks the entry of the hepatitis B and hepatitis D virus into the liver cell, was approved by the European Commission on 31 July 2020. Listen for more of their conversation.
Consider donating here to support programs like B Heppy!
Questions? Send them to: info@hepb.org

Support the Show.

Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook

  continue reading

52 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide